These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28603409)

  • 1. Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients.
    Pongthanaracht N; Yanarojana S; Pinthong D; Unchern S; Thithapandha A; Assantachai P; Supavilai P
    Clin Interv Aging; 2017; 12():897-901. PubMed ID: 28603409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
    Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG
    J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.
    Babaoglu MO; Ocal T; Bayar B; Kayaalp SO; Bozkurt A
    Eur J Clin Pharmacol; 2004 Feb; 59(12):875-7. PubMed ID: 14735258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran.
    Vaisi-Raygani A; Rahimi Z; Entezami H; Kharrazi H; Bahrhemand F; Tavilani H; Rezaei M; Kiani A; Nomanpour B; Pourmotabbed T
    Scand J Clin Lab Invest; 2008; 68(2):123-9. PubMed ID: 17852836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
    Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
    Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Association of Butyrylcholinesterase with Major Depressive Disorder.
    Awan S; Hashmi AN; Taj R; Munir S; Habib R; Batool S; Azam M; Qamar R; Nurulain SM
    Biochem Genet; 2022 Apr; 60(2):720-737. PubMed ID: 34414522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.
    Munir S; Habib R; Awan S; Bibi N; Tanveer A; Batool S; Nurulain SM
    J Mol Neurosci; 2019 Mar; 67(3):445-455. PubMed ID: 30707402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
    Tasker A; Ballard CG; Joachim C; Warden DR; Okello EJ; Perry RH; Khan N; Smith AD; Lehmann DJ; Perry EK
    Neurosci Lett; 2008 Sep; 442(3):297-9. PubMed ID: 18640242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
    Simão-Silva DP; Bertolucci PH; de Labio RW; Payão SL; Furtado-Alle L; Souza RL
    Chem Biol Interact; 2013 Mar; 203(1):358-60. PubMed ID: 23022600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
    Yamamoto Y; Yasuda M; Mori E; Maeda K
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes of butyrylcholinesterase K-variant and their influence on the enzyme activity.
    Jasiecki J; Żuk M; Krawczyńska N; Jońca J; Szczoczarz A; Lewandowski K; Waleron K; Wasąg B
    Chem Biol Interact; 2019 Jul; 307():154-157. PubMed ID: 31071335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
    Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
    Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
    Jasiecki J; Wasąg B
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.